In last trading session, Enveric Biosciences Inc (NASDAQ:ENVB) saw 0.51 million shares changing hands with its beta currently measuring 0.75. Company’s recent per share price level of $0.47 trading at $0.0 or -0.63% at ring of the bell on the day assigns it a market valuation of $4.21M. That closing price of ENVB’s stock is at a discount of -521.28% from its 52-week high price of $2.92 and is indicating a premium of 23.4% from its 52-week low price of $0.36. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.11 million shares which gives us an average trading volume of 478.66K if we extend that period to 3-months.
Enveric Biosciences Inc (NASDAQ:ENVB) trade information
Upright in the red during last session for losing -0.63%, in the last five days ENVB remained trading in the red while hitting it’s week-highest on Friday, 11/08/24 when the stock touched $0.47 price level, adding 10.48% to its value on the day. Enveric Biosciences Inc’s shares saw a change of -63.69% in year-to-date performance and have moved -4.01% in past 5-day. Enveric Biosciences Inc (NASDAQ:ENVB) showed a performance of 8.13% in past 30-days. Number of shares sold short was 0.19 million shares which calculate 0.19 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Enveric Biosciences Inc (ENVB) estimates and forecasts
Statistics highlight that Enveric Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -46.97% of value to its shares in past 6 months, showing an annual growth rate of 74.03% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 71.22% during past 5 years.
Enveric Biosciences Inc (NASDAQ:ENVB)’s Major holders
Insiders are in possession of 7.72% of company’s total shares while institution are holding 5.67 percent of that, with stock having share float percentage of 6.14%. Investors also watch the number of corporate investors in a company very closely, which is 5.67% institutions for Enveric Biosciences Inc that are currently holding shares of the company. ADVISORSHARES INVESTMENTS LLC is the top institutional holder at ENVB for having 0.32 million shares of worth $0.19 million. And as of 2024-06-30, it was holding 7.9233 of the company’s outstanding shares.
The second largest institutional holder is GEODE CAPITAL MANAGEMENT, LLC, which was holding about 44659.0 shares on 2024-06-30. The number of shares represents firm’s hold over 1.1161 of outstanding shares, having a total worth of $27688.0.
